Your English writing platform
Discover LudwigSuggestions(1)
Exact(8)
In this single-center, randomized, parallel-group study that not designed blindly and placebo-controlled manner, 74 patients with mild persistent asthma were treated with either inhaled budesonide 400 μg once daily, oral montelukast 10 mg once daily, or sustained-release theophylline 400 mg once daily for 3 months.
Methods: Thirty-nine patients with uncontrolled moderate-to-severe asthma were treated with 1000 μg of DPI-administered BDP twice daily (DPI-BDP) for 4 weeks and then randomized to 200 μg of HFA-BDP twice daily (n = 20) or 100 μg of FP and 50 μg of SM twice daily (FM-SM; n = 19) for 8 weeks in a double-blind, double-dummy, parallel-group design.
32 cases with serious bronchial asthma were treated by Lei [125] through the conventional treatment using western medicines.
26 All conditions, bar asthma, were treated as unresolvable (ie, permanent).
Patients with HDM-allergic asthma were treated with HDM SCIT plus ICS or placebo plus ICS for 3 years.
Our subjects with severe asthma were treated with high-dose inhaled and/or oral corticosteroids, and therefore this may have attenuated the IL-17A expression in this group.
Similar(52)
These could be cut in half if asthma was treated daily with controller medications".
Soon he hit on a new discovery: a molecule that he thought might fundamentally alter the way asthma was treated.
Many patients with asthma are treated in the primary care setting.
Our case who has rheumatoid arthritis (RA) and bronchial asthma was treated with low dose steroids and methotrexate.
In the Netherlands, children with intermittent and mild asthma are usually treated by a family physician, while patients with more severe or uncontrolled asthma are treated by specialized paediatric care [ 6].
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com